Delivery Order SPE2DB24D9155-SPE2DB25FHZHG
- Not listed
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order contract worth $7,104.00 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. This order is for the delivery of Mirena 52 mg systems, a contraceptive implant, with a completion date of March 5, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract, valued up to $4,999,999, with the Defense...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,083.12 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant device. The contract, issued on July 22, 2025, with an ultimate completion date of August 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation. DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform the work at its Park...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $1,184.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of MIRENA 52 MG SYSTEMS, a contraceptive implant, with a period of performance through April 3, 2024. This delivery order is issued under DMS Pharmaceutical Group's existing indefinite delivery contract SPE2DB20D9354 with the DLA, which has a ceiling value of up...
- The Defense Logistics Agency awarded a delivery order valued at $1,041.56 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, with an ultimate completion date of August 25, 2025. This firm fixed-price delivery order was issued without a set-aside designation and represents a supply of contraceptive medical devices to support Department of Defense healthcare requirements. The work will be performed at the vendor's location in Park Ridge, Illinois. DMS Pharmaceutical Group Inc., a...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,619.20 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a contraceptive product, with a completion date of September 15, 2023. This delivery order is issued under DMS Pharmaceutical Group's single-award, indefinite delivery contract (IDC) with DLA valued at up to...
- The Defense Logistics Agency awarded DMS Pharmaceutical Group Inc. a delivery order valued at $5,207.70 for Mirena 52 mg systems, effective July 21, 2025, with an ultimate completion date of August 11, 2025. This firm fixed-price delivery order represents a discrete procurement under DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with DLA, valued at approximately $500 million through November 2026. The award carries no set-aside designation, allowing the woman-owned small...
- This firm-fixed-price delivery order was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $2,960 contract is for the supply of Mirena 52 mg systems, a type of intrauterine contraceptive device. It was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of June 6, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC)...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $20,720.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of intrauterine contraceptive device. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which covers a wide range of...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $9,472.00 firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business in Park Ridge, Illinois. The contract is for the delivery of MIRENA 20MCG/24HR 1S, a contraceptive implant, with a completion date of March 18, 2024. DMS Pharmaceutical Group holds an indefinite delivery contract with the Defense Logistics Agency, contract 4600082013 under the SPE2DB program, valued at up to $4,999,999...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $3,552.00 to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Mirena 52 mg systems, a type of contraceptive implant. This Delivery Order contract is part of a larger Indefinite Delivery Vehicle (IDV) contract worth up to $4,999,999 that DMS Pharmaceutical Group holds with DLA to provide a broad range of pharmaceutical...
- SPE2DB24D9155Indefinite Delivery Contract
- SPE2DB24D9155-SPE2DB25FHZHGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,603.85 to DMS Pharmaceutical Group Inc. for Mirena 52 mg systems, a contraceptive implant product. The contract, issued on August 5, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed-price pricing and carries no set-aside designation. The place of performance is Park Ridge, Illinois, where DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is headquartered. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, valued at $499,999,999 and valid through November 2026. The parent contract enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a significant supplier in the federal pharmaceutical supply chain, leveraging its woman-owned small business status to compete effectively across the agency's medical supply needs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.6k | 8/5/25 |